Accelerating the Promise of Predictive, Prognostic, Personalized, and Participatory Medicine With Scientific, Operational, and Commercial Acumen GBC Offers Practical Solutions to Turn Expertise and Innovation into Success Neil R. Mucci CEO - GBC Informed, Fast, and Adaptive Approaches to Clinical Research Studies Clinical Trial Management, Quality System Management, and Monitoring Services Biospecimen Acquisition and Biorepository Expertise Committed to Shortening Research and Development Timelines and Maximizing Client Value Accelerating the Promise of Predictive, Prognostic, Personalized, and Participatory Medicine 1234567 Global BioClinical In Vitro Diagnostic Clinical Trial Services Consulting Business Clinical Trials Biospecimens NEWS Global BioClinical is Attending the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting (5/31/25 to 6/2/205)GBC Attending Life Science Innovation Northwest (LSINW) 2025 in Seattle, WA (4/23/25 to 4/24/25)Teal Health Unveils Landmark Study Results Showing Teal Wand™ Self-Collected Samples Match Clinician Collected SamplesGBC Partners with Boudicca DX to Become a One Stop Global Shop for Strategy and Execution for Medical Device & In Vitro Diagnostic Companies GBC BLOG Inbiome’s Bacterial Identification System Secures IVDR CertificationQuest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer’s DiseaseSamantree Histolog ScannerFederal Court Vacates FDA Rule on Laboratory Developed Testing (LDT) Services
